PAIA
MDT icon

Park Avenue Institutional Advisers’s Medtronic MDT Stock Holding History

Park Avenue Institutional Advisers’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-8,867
Closed -$769K – 259
2016
Q2 		$769K Buy
8,867
+9
+0.1% +$728 0.66% 35
2016
Q1 		$664K Sell
8,858
-249
-3% -$18.8K 0.57% 42
2015
Q4 		$701K Sell
9,107
-300
-3% -$22.6K 0.6% 40
2015
Q3 		$630K Sell
9,407
-203
-2% -$15K 0.56% 40
2015
Q2 		$712K Buy
+9,610
New +$734K 0.57% 41

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Park Avenue Institutional Advisers's MDT Position: Q3 2016 in Review

Park Avenue Institutional Advisers sold out of Medtronic (MDT) in Q3 2016, closing a stake of 8,867 shares — an estimated $769K sold.

Park Avenue Institutional Advisers first reported a position in MDT in Q2 2015 and held it in 5 quarters. The position peaked at $769K in Q2 2016. 1,266 funds tracked by Wall St. Rank hold MDT as of Q3 2016.

  • Park Avenue Institutional Advisers reported no remaining Medtronic position as of Q3 2016 after selling out during the quarter.
  • Park Avenue Institutional Advisers sold 8,867 Medtronic shares in Q3 2016, an estimated $769K.
  • Park Avenue Institutional Advisers first reported a position in Medtronic in Q2 2015 and held it in 5 quarters.
  • Park Avenue Institutional Advisers's Medtronic position peaked at $769K in Q2 2016.
  • 1,266 funds tracked by Wall St. Rank held Medtronic as of Q3 2016.

Based on Park Avenue Institutional Advisers's 13F filing for Q3 2016, filed 15 Feb 2017.